CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Conditions:   Lymphoma, Non-Hodgkin;   Diffuse Large B Cell Lymphoma;   Follicular Lymphoma Intervention:   Biological: CD19-targeted Chimeric Antigen Receptor (CAR) T Cells Sponsor:   Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials